The Hydrolysis of Striatal Adenine- and Guanine-Based Purines in a 6-Hydroxydopamine Rat Model of Parkinson’s Disease

By Oses Jean   Batassini Cristiane   Pochmann Daniela   Böhmer Ana   Vuaden Fernanda   Silvestrin Roberta   Oliveira Alcyr   Bonan Carla   Bogo Maurício   Souza Diogo   Portela Luis   Freitas Sarkis João   Souza Tadeu  

Neurochemical Research, Vol. 36, Iss. 2, 2011-02 ,pp. : 215-222

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Different Doses of Estrogen on the Nigrostriatal Dopaminergic System in Two 6-Hydroxydopamine-Induced Lesion Models of Parkinson’s Disease

By Cordellini Marcela   Piazzetta Giovana   Pinto Karin   Delattre Ana   Matheussi Francesca   Carolino Ruither   Szawka Raphael   Anselmo-Franci Janete   Ferraz Anete  

Neurochemical Research, Vol. 36, Iss. 6, 2011-06 ,pp. : 955-961

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of Enhanced Behavioral Responses tol-DOPA Following Repeated Administration in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease

By Henry B.   Crossman A.R.   Brotchie J.M.  

Experimental Neurology, Vol. 151, Iss. 2, 1998-06 ,pp. : 334-342

Elsevier

Access to resources Recommend Favorite

Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: Implications for the pathogenesis of Parkinson’s disease

By Elkon Hanoch   Melamed Eldad   Offen Daniel  

Journal of Molecular Neuroscience, Vol. 24, Iss. 3, 2004-10 ,pp. : 387-400

Humana Press, Inc

Access to resources Recommend Favorite

Neuromodulatory effect of progesterone on the dopaminergic, glutamatergic, and GABAergic activities in a male rat model of Parkinson’s disease

By Casas Sebasti醤  

Neurological Research, Vol. 35, Iss. 7, 2013-09 ,pp. : 719-725

Maney Publishing

Access to resources Recommend Favorite